NYSE$CI

Cigna Group · Q3 2024 earnings

Q3 2024 earnings · · Investor relations

Briefing

The Cigna Group reported strong results for Q3 2024, driven by focused execution across Evernorth Health Services and Cigna Healthcare.

The Cigna Group reported a 30% increase in total revenues, reaching $63.7 billion. Adjusted income from operations increased by 5% to $2.1 billion, driven by strong contributions from Evernorth Health Services. The company reaffirmed its 2024 adjusted EPS outlook of at least $28.40.

  • Total revenues for Q3 2024 increased 30% to $63.7 billion.
  • Shareholders’ net income for Q3 2024 was $0.7 billion, or $2.63 per share.
  • Adjusted income from operations for Q3 2024 was $2.1 billion, or $7.51 per share.
  • The company reaffirms its 2024 outlook for adjusted income from operations of at least $28.40 per share.

Headline financials

Total Revenue

$63.7B

Previous: $49B+29.9%
EPS

$2.63

Previous: $6.77-61.2%
Adjusted EPS

$7.51

No prior period
SG&A Expense Ratio

5.6%

No prior period
Adj. SG&A Ratio

5.5%

No prior period
Medical Care Ratio

82.8%

No prior period
Total Customer Relationships

183.5M

No prior period
Pharmacy Customers

120.0M

No prior period
Medical Customers

19.0M

No prior period
Capital Expenditures

-$399M

No prior period
Free Cash Flow

$825M

Previous: $1.45B-43.1%
Net Income

$825M

Previous: $1.45B-43.1%
Operating Income

$2.58B

Previous: $2.24B+15.0%
Gross Profit

$16.1B

Previous: $15.4B+4.7%
Cash & Equivalents

$5.89B

Previous: $8.5B-30.7%
Total Assets

$158B

Previous: $150B+5.3%

Revenue & EPS history

Cigna · Revenue · Quarterly

$63.7B

Q3 2024+29.9%vs Q3 2023
Beat estimate in 12 of 15 quarters(80%)
ActualEstimate

Forward guidance

The Cigna Group’s outlook for full year 2024 consolidated adjusted income from operations is at least $28.40 per share. This outlook includes the impact of expected future share repurchases and anticipated 2024 dividends.

Tailwinds

  • Adjusted Income from Operations, per share at least $28.40
  • Evernorth Adjusted Income from Operations, Pre-Tax at least $7,000 million
  • Cigna Healthcare Adjusted Income from Operations, Pre-Tax at least $4,775 million
  • Cigna Healthcare Medical Care Ratio 81.7% to 82.5%
  • Includes the impact of expected future share repurchases and anticipated 2024 dividends.

Headwinds

  • Actual results may differ materially depending on a number of factors.
  • Management does not assume any obligation to update these estimates.
  • The Company’s outlook excludes the potential effects of any other business combinations that may occur after the date of this earnings release.
  • The timing and actual number of shares repurchased will depend on a variety of factors, including price, general business and market conditions, and alternate uses of capital.
  • The program may be suspended or discontinued at any time.

Historical earnings impact

How earnings announcements have historically affected this stock's price.

Avg. return before/after earnings

Based on 20 quarterly earnings reports · overlaid with Q3 2024

Historical avgQ3 2024

-0.9%

Avg return

Earnings day

-1.1%

Avg return

5 days after

-0.4%

Avg return

30 days after

48%

31 / 65 earnings

Positive

+8.6%

Q1 2023

Best reaction

-17.4%

Q3 2025

Worst reaction

Earnings price reactions
QuarterReport dateReaction (Day 0)+5 days+30 days
Q1 2026-2.5%-5.7%-5.2%
Q4 2025-0.6%-5.7%-5.2%
Q3 2025-17.4%-11.5%-7.3%
Q2 2025-10.2%-9.1%+1.0%
Q1 2025-0.5%-0.2%-5.5%
Q4 2024-6.7%-3.9%+1.8%
Q3 2024+1.2%+1.8%+8.0%
Q2 2024-3.3%-5.6%+3.8%
Q1 2024-4.4%-2.9%-3.5%
Q4 2023+4.5%+7.6%+8.3%
Q3 2023+0.4%-4.6%-13.1%
Q2 2023-4.3%-2.4%-7.6%
Q1 2023+8.6%+8.1%+5.5%
Q4 2022-4.3%-3.8%-4.8%
Q3 2022+0.4%+2.1%+2.0%
Q2 2022+3.7%+4.9%+5.9%
Q1 2022+4.4%+1.9%-0.7%
Q4 2021-3.8%+0.8%+5.0%
Q3 2021-1.9%-0.9%-8.4%
Q2 2021-9.6%-8.9%-6.3%
Q1 2021+3.9%+0.7%-1.6%
Q4 2020-7.3%-3.8%+5.1%
Q3 2020-4.3%+4.5%+3.3%
Q2 2020-5.0%-4.6%-0.4%
Q1 2020-4.5%-2.8%+0.7%
Q4 2019+1.2%+4.2%-5.3%
Q3 2019+1.7%+3.1%+13.3%
Q2 2019-3.1%-3.6%-9.4%
Q1 2019-5.7%-4.2%-8.6%
Q4 2018-3.9%-6.2%-10.8%
Q3 2018-0.3%+0.2%+4.5%
Q2 2018+3.5%+2.9%+3.0%
Q1 2018-0.7%-1.0%-0.9%
Q4 2017-1.9%-5.2%-7.3%
Q3 2017+2.1%+3.9%+5.3%
Q2 2017-0.0%+1.2%+4.0%
Q1 2017+3.2%+3.9%+4.9%
Q4 2016+1.1%+0.2%+2.9%
Q3 2016+3.2%+9.3%+13.2%
Q2 2016-6.8%-8.4%-6.1%
Q1 2016-2.6%
Q4 2015+0.4%
Q3 2015+0.4%
Q2 2015-0.9%
Q1 2015-0.9%
Q4 2014+1.5%
Q3 2014+5.9%
Q2 2014-2.9%
Q1 2014+3.3%
Q4 2013-10.1%
Q3 2013+5.0%
Q2 2013-0.7%
Q1 2013+2.7%
Q4 2012+3.8%
Q3 2012+4.1%
Q2 2012+4.6%
Q1 2012-2.8%
Q4 2011+2.9%
Q3 2011-6.0%
Q2 2011+1.8%
Q1 2011+2.4%
Q4 2010+4.3%
Q3 2010+2.0%
Q2 2010-6.3%
Q1 2010+1.6%

Discussion

Share your read of this quarter. Sign-in carries your eToro identity.

Join the conversation

Sign in with eToro to post your read of this quarter and vote on others'.

Sign in with eToro